跳至主要内容
临床试验/NCT02822053
NCT02822053Unknown1 期

Effectivity and Safety of Ultrasound-guided Percutaneously Laser Ablation for Refractory Neoplasms

First Affiliated Hospital of Zhejiang University1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2016年4月1日最近更新:
适应症

试验速览

阶段
1 期
发起方
入组人数
100
试验地点
1
主要终点
100 patients of refractory neoplasms with image-guided laser ablation-related effectivity as assessed by MRI

研究概览

简要总结

The purpose of this study is to evaluate the safety and efficacy of ultrasonography (US) -guided laser ablation liver, kidney, pancreas, lung and retroperitoneal tumors, the investigators used preoperative and postoperative US/CEUS/CT/MRI to assess lesions, and laboratory tests including the tumor markers to evaluate the general condition of patients. Intraoperative US/CEUS/CT would be applied to monitor ablation lesions.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 100 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with small hepatocellular carcinoma (single or multiple nodules of less than 3 cm in diameter),
  • Patients with Child-Pugh A/B,
  • Patients with PLT ≥ 50*10E9/L and PT ≤ 20s.

排除标准

  • Patients with blood coagulation dysfunction, ChildPugh ≥3, severe cardiopulmonary disease, intolerant anesthesia and upper gastrointestinal bleeding in shock.

结局指标

主要结局

100 patients of refractory neoplasms with image-guided laser ablation-related effectivity as assessed by MRI

时间窗: up to 24 months

次要结局

未报告次要终点

研究者

发起方
First Affiliated Hospital of Zhejiang University
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验